Division of Medical Oncology, Mayo Clinic, Rochester, USA
Biography
Dr. Mahipal is also involved in the development of novel therapeutic agents for gastrointestinal cancers. He is a member of Phase 1 clinical trial program at Mayo clinic and involved in drug development for oncology patients. He is the principal investigator for several early phase clinical trials including first-in-human studies. He has spearheaded several investigator initiated trials for pancreatic, liver and bile duct cancers.